News from palatin technologies, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Aug 18, 2015, 20:13 ET
Palatin Technologies Reconnect Study Logo

Palatin Technologies Supports FDA's Approval of the First-Ever Treatment for Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN) is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Jul 06, 2015, 07:30 ET

Palatin Technologies Completes $30 Million Financing

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Jun 04, 2015, 17:35 ET

Palatin Supports FDA Advisory Committee's Recommendation to Approve the First-Ever Treatment for Hypoactive Sexual Desire Disorder

 Palatin Technologies, Inc. (NYSE Amex: PTN) - Today's FDA Advisory Committee's recommendation for the approval of flibanserin is an important...

May 13, 2015, 07:30 ET
Palatin Technologies Reconnect Study Logo

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on May 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

May 08, 2015, 07:30 ET

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2015 Results

Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its third quarter, fiscal year 2015 operating results on Wednesday, May 13, 2015 before...

Mar 06, 2015, 16:01 ET

Palatin Technologies To Present At The 27th Annual ROTH Conference

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that it will be presenting at the 27th Annual ROTH Conference on Wednesday, March...

Feb 20, 2015, 07:30 ET
reconnect study

Palatin Launches reconnectstudy.com in Support of Bremelanotide Phase 3 Program for Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Feb 13, 2015, 07:30 ET
Palatin Technologies Reconnect Study Logo

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on February 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Feb 09, 2015, 16:39 ET

Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2015 Results Teleconference and Webcast to be held on February 13, 2015

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its second quarter, fiscal year 2015 operating results on Friday, February...

Feb 06, 2015, 16:01 ET

Palatin Technologies To Present At The BIO CEO & Investor Conference

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting at the 17th Annual BIO CEO & Investor Conference. Hosted...

Dec 29, 2014, 07:30 ET
reconnect study

Palatin Announces Start of Bremelanotide Phase 3 Program For Female Sexual Dysfunction

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Dec 24, 2014, 07:30 ET

Palatin Completes $20 Million Equity and $10 Million Debt Financings

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Nov 18, 2014, 07:30 ET

Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2015 Results; Teleconference and Webcast to be held on November 18, 2014

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Nov 13, 2014, 16:30 ET

Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2015 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2015 operating results on Tuesday, November 18, 2014...

Nov 04, 2014, 09:05 ET

Survey Reveals Low Sexual Desire Disrupts Relationships

Nearly one in two non-menopausal women ages 30 to 50 say they have experienced low sexual desire at some point in their lives, and many of these...

Oct 08, 2014, 07:30 ET

Palatin Technologies To Present At The 13th Annual BIO Investor Forum

 Palatin Technologies, Inc. (NYSE MKT: PTN) announced that it will be presenting today at the 13th Annual BIO Investor Forum at 11:00 a.m....

Sep 09, 2014, 07:30 ET

Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2014 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...

Sep 04, 2014, 16:58 ET

Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results

 Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its fourth quarter, fiscal year 2014 operating results on Tuesday, September 9, 2014...

Sep 03, 2014, 02:00 ET

Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter

Palatin Technologies, Inc. (NYSE MKT: PTN; hereinafter: "Palatin") and Gedeon Richter Plc. (hereinafter: "Richter") announced that they have...

Jul 09, 2014, 07:30 ET

Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides

Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the...